Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Egg harvesting for stem cell research

14.08.2006
Women’s health and human rights advocates worldwide are increasingly concerned that overzealous pursuit of new scientific discoveries may once again be threatening women’s health. This time, young women are being asked to donate or sell their ova, not only for use in fertility clinics, but increasingly for non-clinical use in experimental cloning research.

Diane Beeson and Abby Lippman, based at California State University and McGill University, Montreal respectively, report on medical risks and ethical problems associated with collection of human oocytes (eggs) during IVF practice from donors who give them to other women who desperately want a child. Doubts are emerging about donating oocytes in this manner, even when recipients use them to establish a pregnancy. Their article Egg harvesting for stem cell research: medical risks and ethical problems is published in the journal Reproductive BioMedicine Online [www.rbmonline.com/Article/2503 – e-pub ahead of print 14 August 2006].

Widely practised in IVF, but not yet proven to be fully safe, various hormones are given to donors to stimulate several eggs to develop. Using ultrasound, ripe oocytes are then aspirated from within their follicles. The oocytes are often donated free, although the HFEA has given permission for donors to receive some compensation via discounts for their own IVF treatment. In one case reported, the donor oocytes were needed for stem cell research, which makes ethicists even more furious about ‘selling’ human oocytes.

It is hard to separate ethically this decision from giving direct payments to donors, or from fertilizing the eggs and then giving them away for research. In all these examples, many donors might have suffered from mild symptoms of ovarian hyperstimulation, among other disorders, without their knowledge.

Recent research has stressed the risks of using hormonal stimulants to induce follicle growth and ovulation in women. Surprisingly, Beeson and Lippman claim that pharmaceutical companies have not been compelled to submit their information on the risks of such forms of ovulation induction to the US Food and Drug Administration. Claims are made of 25 deaths among donors, although this requires verification. Claims that cancers may be induced in some patients have been questioned or denied, although an increase arose in another study on >3500 women donors, and critics stress that many of these studies had short-term follow-ups in only a few women. These patients were among the first to attempt IVF, and their risks of tumours are now emerging and will be analysed in the near future.

IVF children have not yet displayed such anomalies, though significant abnormalities are reported in offspring of mice following similar treatments. These investigating authors nevertheless cited earlier reports on anomalies, including cancers, in offspring of women receiving exogenous hormones, perhaps due to the release of steroids. In view of all these known and unknown risks to women donors, these authors refer to organizations established to protect women undergoing IVF and other ovarian treatments. It is one thing, however, to raise a fuss about uncertain risks but quite another to gain hard data from the complex reports emerging in the world of assisted human conception.

Fiona Bennett | alfa
Further information:
http://www.rbmonline.com/Article/2503

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Why might reading make myopic?

18.07.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>